Phenylketonuria (PKU) is an inherited metabolic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase, which results in a disorder of the metabolism of the amino acid phenylalanine. Without adequate treatment, phenylalanine levels in the body increase, which can cause severe neurological consequences and developmental disabilities. PKU is one of the most common examples of inherited metabolic disorders and requires early diagnosis and ongoing monitoring to prevent serious complications.
History of the disease and interesting historical facts
Phenylketonuria was first described in 1934 by Swedish physician Arne Krey, who noticed phenylalanine in the urine of patients. Until that time, the disease remained unknown, and patients often suffered from neurological disorders without an obvious cause. In the 1950s, methods for screening newborns for PKU began to be developed, which significantly improved the prognosis for children with the disease. These diagnostic methods have become standard in many countries and are an important step in preventing PKU-related disabilities. One of the most significant moments in the history of the disease occurred in the early 1980s, when a strict phenylalanine-restricted diet was introduced, allowing patients to lead full lives with minimal restrictions.
Epidemiology
The epidemiology of phenylketonuria varies by geographic region and ethnicity. On average, the prevalence of PKU is 1 in 10,000 to 15,000 births in populations of European descent. However, there is significant variation in prevalence, which can be as high as 1 in 4,500 births in certain populations, such as Scandinavian countries. According to various sources, PKU is less common in African and Asian races, which is due to changes in the genetic background and mutations that lead to the disease.
Genetic predisposition to this disease
Phenylketonuria is caused by mutations in the PAH (phenylalanine hydroxylase) gene, located on chromosome 12. This gene encodes an enzyme necessary for the conversion of phenylalanine to tyrosine. To date, more than 900 different mutations of this gene have been registered, indicating its genetic heterogeneity. The most common mutations are R408W, Q192R, and IVS10+11G>A. PKU is inherited in an autosomal recessive manner, which suggests that the defective gene must be inherited from both parents in order to develop the disease.
Risk factors for the development of this disease
Phenylketonuria is a hereditary disease, and specific genetic mutations can be considered risk factors. There are several factors that contribute to an increased risk of the disease:
- Family history of the disease – the presence of people with PKU in the family increases the likelihood of inheriting mutations.
- Ethnicity – Some ethnic groups, such as Ashkenazi Jews, have a higher risk of developing PKU.
- Disadvantages of prenatal screening – the lack of available diagnostic tests in newborns can be a risk factor.
Diagnosis of this disease
Diagnosis of phenylketonuria includes a number of methods:
- Main symptoms – PKU can manifest as mental retardation, developmental delay, seizures, and, in newborns, a characteristic “mousy” odor due to the accumulation of phenylalanine.
- Laboratory research – Blood analysis for phenylalanine and other amino acids is the main diagnostic method. Newborns usually undergo such a test in the first weeks of life.
- Radiological examinations – Magnetic resonance imaging can be used to assess the condition of the brain and identify possible changes.
- Other types of disease diagnostics – genetic tests to detect mutations in the PAH gene.
- Differential diagnosis – it is necessary to exclude other metabolic disorders, such as tyrosinemia and other hereditary metabolic disorders.
Treatment
Treatment of phenylketonuria involves a comprehensive approach to controlling blood phenylalanine levels:
- General treatment – following a low-phenylalanine diet, which limits the consumption of foods rich in phenylalanine.
- Pharmacological treatment – special preparations containing tyrosine and other amino acids are used, which can help compensate for the deficiency.
- Surgical treatment – in rare cases, surgical interventions may be required, but such a need arises extremely rarely.
- Other types of treatment – the use of specialized formula mixtures for nutrition, vitamins and supplements to maintain normal metabolism.
List of medications used to treat this disease
List of drugs used to correct disorders in PKU:
- Tyrosine (amino acid)
- Bentoic acids (to reduce phenylalanine levels)
- Mixtures for specialized nutrition
- Vitamin complexes (as needed)
Disease monitoring
Monitoring the condition of a patient with phenylketonuria includes:
- Control stages – regular checks of blood phenylalanine levels every few weeks or months.
- Forecast – with diet and monitoring, patients' condition can be stable and they can lead a full life.
- Complications – if left untreated, mental retardation, seizures and other neurological disorders may develop.
Age-related features of the disease
Phenylketonuria manifests itself at different stages of life. In most cases, the disease is diagnosed in newborns. Strict adherence to the diet is important during infancy, as it is especially critical to prevent the accumulation of phenylalanine at this stage. Older children and adolescents may experience learning and behavioral problems if phenylalanine levels are not properly controlled. Adult patients may sometimes neglect the diet, leading to deterioration of the condition, so monitoring and support throughout life are important.
Questions and Answers
- What is phenylketonuria? Phenylketonuria is an inherited metabolic disorder associated with a deficiency of the enzyme phenylalanine hydroxylase, resulting in accumulation of phenylalanine and neurological impairment.
- How is PKU diagnosed? Diagnosis is made using a blood test for phenylalanine levels, genetic tests and other examinations to exclude concomitant diseases.
- What treatment is needed for PKU? Treatment includes strict adherence to a low-tyrosine diet, the use of special drugs and vitamins to compensate for the lack of tyrosine.
- What are the complications if left untreated? Without treatment, mental retardation, seizures, developmental delays and serious neurological disorders may develop.
- What are the risk factors for PKU? Major risk factors include family history, certain ethnic groups, and inadequate newborn screening.
